Sarepta Therapeutics Inc (NASDAQ:SRPT), was a big mover last session, as its shares rose over 39% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company as the stock is now trading above the volatile price range of $22.18 to $25.80 in the past one-month timeframe. Sarepta Therapeutics Inc (NASDAQ:SRPT), Magellan Petroleum Corporation (NASDAQ:MPET), shares after opening at $34.56 moved to $39.20 on last trade day and at the end of the day closed at $38.79. Company price to sales ratio in past twelve months was calculated as 103.18 and price to cash ratio as 5.70. Sarepta Therapeutics Inc (NASDAQ:SRPT), showed a positive weekly performance of 74.02%.
Revance Therapeutics Inc (NASDAQ:RVNC), is a $643 million specialty therapeutic company. Its main focus is the development of better aesthetic products, and its industry is among the fastest growing in the therapeutic space. Revance Therapeutics Inc (NASDAQ:RVNC), shares advanced 25.75% in last trading session and ended the day on $35.99.
MacroGenics Inc (NASDAQ:MGNX), had its target price lifted by Stifel Nicolaus from $51.00 to $53.00 in a research note released on Friday morning, Analyst RN reports. MacroGenics Inc (NASDAQ:MGNX), shares moved up 0.68% in last trading session and was closed at $19.21, while trading in range of $ 18.52 – 19.79. MacroGenics Inc (NASDAQ:MGNX), year to date (YTD) performance is -29.97%.
On March 21, 2014, EntreMed Inc (NASDAQ:ENMD), issued a press release reporting its financial results for the three month period and fiscal year ending December 31, 2013. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. EntreMed Inc (NASDAQ:ENMD), weekly performance is 5.91%. On last trading day company shares ended up $1.97. EntreMed Inc (NASDAQ:ENMD), distance from 50-day simple moving average (SMA50) is 5.51%. Analysts mean target Price for the company is $1.00.